# Response to Clozapine in Treatment Resistant Schizophrenia: A Longitudinal Magnetic Resonance Spectroscopy Study

> **NCT02714894** · — · UNKNOWN · sponsor: **Centre for Addiction and Mental Health** · enrollment: 108 (estimated)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Clozapine

## Key facts

- **NCT ID:** NCT02714894
- **Lead sponsor:** Centre for Addiction and Mental Health
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-04
- **Primary completion:** 2022-07-30
- **Final completion:** 2022-07-30
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2022-06-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02714894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02714894, "Response to Clozapine in Treatment Resistant Schizophrenia: A Longitudinal Magnetic Resonance Spectroscopy Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02714894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*